Evidence map›Paper›PMID 20661294›Full record

ArticlePloS one2010

Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics.

Christy L Ventura, Natalia Malachowa, Carl H Hammer, Glenn A Nardone, Mary Ann Robinson, Scott D Kobayashi, Frank R DeLeo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 206 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  5. Prevalence of Variant GTRAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Strategies for Survival ofInternational journal of molecular sciences · 2025
    Review
  7. Characterisation ofToxins · 2025
    Article
  8. Article
  9. Surface-Shaving ofMicroorganisms · 2024
    Article
  10. Infection and immunity · 2024
    Article
  11. Molecular Characteristics and Pathogenicity ofInternational journal of molecular sciences · 2023
    Review
  12. Autolysin-mediated peptidoglycan hydrolysis is required for the surface display ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Analysis of the Presence of the Virulence and Regulation Genes fromInternational journal of environmental research and public health · 2023
    Article
  14. Microbes and the fate of neutrophils.Immunological reviews · 2023
    Review
  15. Article
  16. Article
  17. Sequence Analysis of NovelInternational journal of molecular sciences · 2022
    Article
  18. Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  19. StaphylococcalInternational journal of molecular sciences · 2022
    Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Christy L VenturaLaboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Natalia Malachowa
Carl H Hammer
Glenn A Nardone
Mary Ann Robinson
Scott D Kobayashi
Frank R DeLeo
National Institute of Allergy and Infectious Diseases · USENT and Allergy · USNational Institutes of Health · USRocky Mountain Biological Laboratory · US

Funding

Infectious Diseases Research Technologies Core - BethesdaZICAI001051 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$226.1M
Mechanisms of Staphylococcus aureus virulenceZIAAI001079 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2009 to 2025
$11.8M
Intramural NIH HHS
6 · The paper itself

Abstract

Staphylococcus aureus is a prominent human pathogen and leading cause of bacterial infection in hospitals and the community. Community-associated methicillin-resistant S. aureus (CA-MRSA) strains such as USA300 are highly virulent and, unlike hospital strains, often cause disease in otherwise healthy individuals. The enhanced virulence of CA-MRSA is based in part on increased ability to produce high levels of secreted molecules that facilitate evasion of the innate immune response. Although progress has been made, the factors that contribute to CA-MRSA virulence are incompletely defined. We analyzed the cell surface proteome (surfome) of USA300 strain LAC to better understand extracellular factors that contribute to the enhanced virulence phenotype. A total of 113 identified proteins were associated with the surface of USA300 during the late-exponential phase of growth in vitro. Protein A was the most abundant surface molecule of USA300, as indicated by combined Mascot score following analysis of peptides by tandem mass spectrometry. Unexpectedly, we identified a previously uncharacterized two-component leukotoxin-herein named LukS-H and LukF-G (LukGH)-as two of the most abundant surface-associated proteins of USA300. Rabbit antibody specific for LukG indicated it was also freely secreted by USA300 into culture media. We used wild-type and isogenic lukGH deletion strains of USA300 in combination with human PMN pore formation and lysis assays to identify this molecule as a leukotoxin. Moreover, LukGH synergized with PVL to enhance lysis of human PMNs in vitro, and contributed to lysis of PMNs after phagocytosis. We conclude LukGH is a novel two-component leukotoxin with cytolytic activity toward neutrophils, and thus potentially contributes to S. aureus virulence.

Indexed as

Bacterial ProteinsCell MembraneCells, CulturedElectrophoresis, Polyacrylamide GelExotoxinsHumansImmunoblottingMass SpectrometryNeutrophilsProteomicsStaphylococcus aureusBacterial ProteinsExotoxinsleukotoxin

Identifiers

PMID20661294
PMCPMC2905442
OpenAlexW2080732258

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.